Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a publicly traded Healthcare sector company. As of October 12, 2026, CTNM trades at $9.97 with a market cap of $503.37M and a P/E ratio of -6.00. CTNM moved -21.90% today. Year to date, CTNM is +17.06%; over the trailing twelve months it is +10.03%. Its 52-week range spans $3.35 to $17.79. Analyst consensus is strong buy with an average price target of $22.29. Rallies surfaces CTNM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CTNM moved -21.90% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $9.97 |
| Market Cap | $503.37M |
| P/E Ratio | -6.00 |
| EPS | $-2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.79 |
| 52-Week Low | $3.35 |
| Volume | 2.99M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-59.98M |
| Gross Margin | 0.00% |
8 analysts cover CTNM: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $22.29.